nodes	percent_of_prediction	percent_of_DWPC	metapath
Apraclonidine—Paraesthesia—Tacrolimus—atopic dermatitis	0.00111	0.00113	CcSEcCtD
Apraclonidine—Conjunctivitis—Triamcinolone—atopic dermatitis	0.0011	0.00112	CcSEcCtD
Apraclonidine—Bradycardia—Hydrocortisone—atopic dermatitis	0.0011	0.00112	CcSEcCtD
Apraclonidine—Dyspnoea—Tacrolimus—atopic dermatitis	0.0011	0.00112	CcSEcCtD
Apraclonidine—Somnolence—Tacrolimus—atopic dermatitis	0.0011	0.00112	CcSEcCtD
Apraclonidine—Pruritus—Mometasone—atopic dermatitis	0.0011	0.00112	CcSEcCtD
Apraclonidine—Haemorrhage—Hydrocortisone—atopic dermatitis	0.00108	0.0011	CcSEcCtD
Apraclonidine—Dizziness—Fluocinolone Acetonide—atopic dermatitis	0.00107	0.00109	CcSEcCtD
Apraclonidine—Nausea—Loratadine—atopic dermatitis	0.00107	0.00109	CcSEcCtD
Apraclonidine—Visual impairment—Prednisolone—atopic dermatitis	0.00107	0.00109	CcSEcCtD
Apraclonidine—Gastrointestinal disorder—Tacrolimus—atopic dermatitis	0.00106	0.00108	CcSEcCtD
Apraclonidine—Fatigue—Tacrolimus—atopic dermatitis	0.00106	0.00108	CcSEcCtD
Apraclonidine—Diarrhoea—Mometasone—atopic dermatitis	0.00106	0.00108	CcSEcCtD
Apraclonidine—Constipation—Tacrolimus—atopic dermatitis	0.00105	0.00107	CcSEcCtD
Apraclonidine—Pain—Tacrolimus—atopic dermatitis	0.00105	0.00107	CcSEcCtD
Apraclonidine—Bradycardia—Triamcinolone—atopic dermatitis	0.00104	0.00106	CcSEcCtD
Apraclonidine—Bradycardia—Methylprednisolone—atopic dermatitis	0.00104	0.00105	CcSEcCtD
Apraclonidine—Vomiting—Fluocinolone Acetonide—atopic dermatitis	0.00103	0.00105	CcSEcCtD
Apraclonidine—Dermatitis—Fluocinolone Acetonide—atopic dermatitis	0.00102	0.00104	CcSEcCtD
Apraclonidine—Rhinitis—Triamcinolone—atopic dermatitis	0.00102	0.00104	CcSEcCtD
Apraclonidine—Rhinitis—Methylprednisolone—atopic dermatitis	0.00102	0.00104	CcSEcCtD
Apraclonidine—Haemorrhage—Triamcinolone—atopic dermatitis	0.00102	0.00104	CcSEcCtD
Apraclonidine—Haemorrhage—Methylprednisolone—atopic dermatitis	0.00102	0.00104	CcSEcCtD
Apraclonidine—Headache—Fluocinolone Acetonide—atopic dermatitis	0.00102	0.00104	CcSEcCtD
Apraclonidine—Feeling abnormal—Tacrolimus—atopic dermatitis	0.00102	0.00103	CcSEcCtD
Apraclonidine—Pharyngitis—Triamcinolone—atopic dermatitis	0.00101	0.00103	CcSEcCtD
Apraclonidine—Eye disorder—Hydrocortisone—atopic dermatitis	0.00101	0.00103	CcSEcCtD
Apraclonidine—Gastrointestinal pain—Tacrolimus—atopic dermatitis	0.00101	0.00103	CcSEcCtD
Apraclonidine—Conjunctivitis—Dexamethasone—atopic dermatitis	0.001	0.00102	CcSEcCtD
Apraclonidine—Conjunctivitis—Betamethasone—atopic dermatitis	0.001	0.00102	CcSEcCtD
Apraclonidine—Arrhythmia—Prednisolone—atopic dermatitis	0.00099	0.00101	CcSEcCtD
Apraclonidine—Vomiting—Mometasone—atopic dermatitis	0.000985	0.001	CcSEcCtD
Apraclonidine—Visual impairment—Methylprednisolone—atopic dermatitis	0.00098	0.000998	CcSEcCtD
Apraclonidine—Dermatitis—Mometasone—atopic dermatitis	0.000976	0.000994	CcSEcCtD
Apraclonidine—Abdominal pain—Tacrolimus—atopic dermatitis	0.000975	0.000993	CcSEcCtD
Apraclonidine—Headache—Mometasone—atopic dermatitis	0.000971	0.000988	CcSEcCtD
Apraclonidine—Arrhythmia—Hydrocortisone—atopic dermatitis	0.000967	0.000985	CcSEcCtD
Apraclonidine—Erythema—Prednisolone—atopic dermatitis	0.000965	0.000983	CcSEcCtD
Apraclonidine—Nausea—Fluocinolone Acetonide—atopic dermatitis	0.000964	0.000982	CcSEcCtD
Apraclonidine—Eye disorder—Methylprednisolone—atopic dermatitis	0.000951	0.000968	CcSEcCtD
Apraclonidine—Mental disorder—Hydrocortisone—atopic dermatitis	0.000949	0.000966	CcSEcCtD
Apraclonidine—Erythema—Hydrocortisone—atopic dermatitis	0.000942	0.00096	CcSEcCtD
Apraclonidine—Bradycardia—Betamethasone—atopic dermatitis	0.000942	0.000959	CcSEcCtD
Apraclonidine—Bradycardia—Dexamethasone—atopic dermatitis	0.000942	0.000959	CcSEcCtD
Apraclonidine—Haemorrhage—Betamethasone—atopic dermatitis	0.000925	0.000942	CcSEcCtD
Apraclonidine—Haemorrhage—Dexamethasone—atopic dermatitis	0.000925	0.000942	CcSEcCtD
Apraclonidine—Angiopathy—Methylprednisolone—atopic dermatitis	0.000923	0.00094	CcSEcCtD
Apraclonidine—Nausea—Mometasone—atopic dermatitis	0.00092	0.000937	CcSEcCtD
Apraclonidine—Mediastinal disorder—Methylprednisolone—atopic dermatitis	0.000917	0.000934	CcSEcCtD
Apraclonidine—Arrhythmia—Triamcinolone—atopic dermatitis	0.000911	0.000928	CcSEcCtD
Apraclonidine—Vision blurred—Prednisolone—atopic dermatitis	0.000909	0.000926	CcSEcCtD
Apraclonidine—Arrhythmia—Methylprednisolone—atopic dermatitis	0.000909	0.000925	CcSEcCtD
Apraclonidine—Hypersensitivity—Tacrolimus—atopic dermatitis	0.000908	0.000925	CcSEcCtD
Apraclonidine—Ill-defined disorder—Prednisolone—atopic dermatitis	0.000895	0.000912	CcSEcCtD
Apraclonidine—Visual impairment—Dexamethasone—atopic dermatitis	0.000891	0.000908	CcSEcCtD
Apraclonidine—Visual impairment—Betamethasone—atopic dermatitis	0.000891	0.000908	CcSEcCtD
Apraclonidine—Mental disorder—Methylprednisolone—atopic dermatitis	0.000891	0.000908	CcSEcCtD
Apraclonidine—Erythema—Triamcinolone—atopic dermatitis	0.000887	0.000904	CcSEcCtD
Apraclonidine—Erythema—Methylprednisolone—atopic dermatitis	0.000885	0.000902	CcSEcCtD
Apraclonidine—Asthenia—Tacrolimus—atopic dermatitis	0.000885	0.000901	CcSEcCtD
Apraclonidine—Ill-defined disorder—Hydrocortisone—atopic dermatitis	0.000874	0.000891	CcSEcCtD
Apraclonidine—Pruritus—Tacrolimus—atopic dermatitis	0.000872	0.000888	CcSEcCtD
Apraclonidine—Malaise—Prednisolone—atopic dermatitis	0.00087	0.000886	CcSEcCtD
Apraclonidine—Dysgeusia—Triamcinolone—atopic dermatitis	0.000869	0.000885	CcSEcCtD
Apraclonidine—Syncope—Prednisolone—atopic dermatitis	0.000865	0.000881	CcSEcCtD
Apraclonidine—Eye disorder—Betamethasone—atopic dermatitis	0.000864	0.00088	CcSEcCtD
Apraclonidine—Eye disorder—Dexamethasone—atopic dermatitis	0.000864	0.00088	CcSEcCtD
Apraclonidine—Malaise—Hydrocortisone—atopic dermatitis	0.00085	0.000866	CcSEcCtD
Apraclonidine—Syncope—Hydrocortisone—atopic dermatitis	0.000845	0.000861	CcSEcCtD
Apraclonidine—Diarrhoea—Tacrolimus—atopic dermatitis	0.000844	0.000859	CcSEcCtD
Apraclonidine—Angiopathy—Dexamethasone—atopic dermatitis	0.000839	0.000855	CcSEcCtD
Apraclonidine—Angiopathy—Betamethasone—atopic dermatitis	0.000839	0.000855	CcSEcCtD
Apraclonidine—Arrhythmia—Betamethasone—atopic dermatitis	0.000826	0.000842	CcSEcCtD
Apraclonidine—Arrhythmia—Dexamethasone—atopic dermatitis	0.000826	0.000842	CcSEcCtD
Apraclonidine—Ill-defined disorder—Triamcinolone—atopic dermatitis	0.000823	0.000839	CcSEcCtD
Apraclonidine—Ill-defined disorder—Methylprednisolone—atopic dermatitis	0.000822	0.000837	CcSEcCtD
Apraclonidine—Bradycardia—Prednisone—atopic dermatitis	0.00082	0.000835	CcSEcCtD
Apraclonidine—Dizziness—Tacrolimus—atopic dermatitis	0.000815	0.00083	CcSEcCtD
Apraclonidine—Discomfort—Prednisolone—atopic dermatitis	0.000812	0.000827	CcSEcCtD
Apraclonidine—Haemorrhage—Prednisone—atopic dermatitis	0.000806	0.00082	CcSEcCtD
Apraclonidine—Erythema—Dexamethasone—atopic dermatitis	0.000805	0.00082	CcSEcCtD
Apraclonidine—Erythema—Betamethasone—atopic dermatitis	0.000805	0.00082	CcSEcCtD
Apraclonidine—Myalgia—Hydrocortisone—atopic dermatitis	0.000802	0.000817	CcSEcCtD
Apraclonidine—Malaise—Triamcinolone—atopic dermatitis	0.0008	0.000815	CcSEcCtD
Apraclonidine—Malaise—Methylprednisolone—atopic dermatitis	0.000799	0.000813	CcSEcCtD
Apraclonidine—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—atopic dermatitis	0.000797	0.000812	CcSEcCtD
Apraclonidine—Syncope—Triamcinolone—atopic dermatitis	0.000796	0.000811	CcSEcCtD
Apraclonidine—Syncope—Methylprednisolone—atopic dermatitis	0.000794	0.000809	CcSEcCtD
Apraclonidine—Discomfort—Hydrocortisone—atopic dermatitis	0.000793	0.000807	CcSEcCtD
Apraclonidine—Oedema—Prednisolone—atopic dermatitis	0.000788	0.000802	CcSEcCtD
Apraclonidine—Vomiting—Tacrolimus—atopic dermatitis	0.000784	0.000798	CcSEcCtD
Apraclonidine—Dermatitis—Tacrolimus—atopic dermatitis	0.000777	0.000791	CcSEcCtD
Apraclonidine—Headache—Tacrolimus—atopic dermatitis	0.000772	0.000787	CcSEcCtD
Apraclonidine—Oedema—Hydrocortisone—atopic dermatitis	0.000769	0.000783	CcSEcCtD
Apraclonidine—Infection—Hydrocortisone—atopic dermatitis	0.000764	0.000778	CcSEcCtD
Apraclonidine—Myalgia—Triamcinolone—atopic dermatitis	0.000756	0.000769	CcSEcCtD
Apraclonidine—Nervous system disorder—Hydrocortisone—atopic dermatitis	0.000754	0.000768	CcSEcCtD
Apraclonidine—Myalgia—Methylprednisolone—atopic dermatitis	0.000754	0.000768	CcSEcCtD
Apraclonidine—Eye disorder—Prednisone—atopic dermatitis	0.000753	0.000767	CcSEcCtD
Apraclonidine—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—atopic dermatitis	0.000749	0.000762	CcSEcCtD
Apraclonidine—Skin disorder—Hydrocortisone—atopic dermatitis	0.000747	0.000761	CcSEcCtD
Apraclonidine—Ill-defined disorder—Betamethasone—atopic dermatitis	0.000747	0.000761	CcSEcCtD
Apraclonidine—Ill-defined disorder—Dexamethasone—atopic dermatitis	0.000747	0.000761	CcSEcCtD
Apraclonidine—Discomfort—Triamcinolone—atopic dermatitis	0.000746	0.00076	CcSEcCtD
Apraclonidine—Discomfort—Methylprednisolone—atopic dermatitis	0.000745	0.000759	CcSEcCtD
Apraclonidine—Dry mouth—Triamcinolone—atopic dermatitis	0.000739	0.000753	CcSEcCtD
Apraclonidine—Nausea—Tacrolimus—atopic dermatitis	0.000732	0.000746	CcSEcCtD
Apraclonidine—Angiopathy—Prednisone—atopic dermatitis	0.000731	0.000744	CcSEcCtD
Apraclonidine—Malaise—Dexamethasone—atopic dermatitis	0.000726	0.00074	CcSEcCtD
Apraclonidine—Malaise—Betamethasone—atopic dermatitis	0.000726	0.00074	CcSEcCtD
Apraclonidine—Oedema—Triamcinolone—atopic dermatitis	0.000724	0.000738	CcSEcCtD
Apraclonidine—Syncope—Dexamethasone—atopic dermatitis	0.000722	0.000735	CcSEcCtD
Apraclonidine—Syncope—Betamethasone—atopic dermatitis	0.000722	0.000735	CcSEcCtD
Apraclonidine—Arrhythmia—Prednisone—atopic dermatitis	0.00072	0.000733	CcSEcCtD
Apraclonidine—Infection—Triamcinolone—atopic dermatitis	0.00072	0.000733	CcSEcCtD
Apraclonidine—Infection—Methylprednisolone—atopic dermatitis	0.000718	0.000731	CcSEcCtD
Apraclonidine—Insomnia—Prednisolone—atopic dermatitis	0.000712	0.000725	CcSEcCtD
Apraclonidine—Nervous system disorder—Methylprednisolone—atopic dermatitis	0.000709	0.000722	CcSEcCtD
Apraclonidine—Paraesthesia—Prednisolone—atopic dermatitis	0.000707	0.00072	CcSEcCtD
Apraclonidine—Mental disorder—Prednisone—atopic dermatitis	0.000706	0.000719	CcSEcCtD
Apraclonidine—Skin disorder—Methylprednisolone—atopic dermatitis	0.000702	0.000715	CcSEcCtD
Apraclonidine—Erythema—Prednisone—atopic dermatitis	0.000701	0.000714	CcSEcCtD
Apraclonidine—Musculoskeletal discomfort—Hydrocortisone—atopic dermatitis	0.000701	0.000714	CcSEcCtD
Apraclonidine—Insomnia—Hydrocortisone—atopic dermatitis	0.000696	0.000709	CcSEcCtD
Apraclonidine—Paraesthesia—Hydrocortisone—atopic dermatitis	0.000691	0.000703	CcSEcCtD
Apraclonidine—Myalgia—Betamethasone—atopic dermatitis	0.000686	0.000698	CcSEcCtD
Apraclonidine—Myalgia—Dexamethasone—atopic dermatitis	0.000686	0.000698	CcSEcCtD
Apraclonidine—Discomfort—Dexamethasone—atopic dermatitis	0.000677	0.00069	CcSEcCtD
Apraclonidine—Discomfort—Betamethasone—atopic dermatitis	0.000677	0.00069	CcSEcCtD
Apraclonidine—Pain—Prednisolone—atopic dermatitis	0.000673	0.000686	CcSEcCtD
Apraclonidine—Gastrointestinal disorder—Hydrocortisone—atopic dermatitis	0.000664	0.000676	CcSEcCtD
Apraclonidine—Fatigue—Hydrocortisone—atopic dermatitis	0.000663	0.000675	CcSEcCtD
Apraclonidine—Vision blurred—Prednisone—atopic dermatitis	0.000661	0.000673	CcSEcCtD
Apraclonidine—Musculoskeletal discomfort—Triamcinolone—atopic dermatitis	0.00066	0.000672	CcSEcCtD
Apraclonidine—Musculoskeletal discomfort—Methylprednisolone—atopic dermatitis	0.000658	0.000671	CcSEcCtD
Apraclonidine—Pain—Hydrocortisone—atopic dermatitis	0.000658	0.00067	CcSEcCtD
Apraclonidine—Oedema—Dexamethasone—atopic dermatitis	0.000657	0.000669	CcSEcCtD
Apraclonidine—Oedema—Betamethasone—atopic dermatitis	0.000657	0.000669	CcSEcCtD
Apraclonidine—Insomnia—Triamcinolone—atopic dermatitis	0.000655	0.000667	CcSEcCtD
Apraclonidine—Insomnia—Methylprednisolone—atopic dermatitis	0.000654	0.000666	CcSEcCtD
Apraclonidine—Infection—Dexamethasone—atopic dermatitis	0.000653	0.000665	CcSEcCtD
Apraclonidine—Infection—Betamethasone—atopic dermatitis	0.000653	0.000665	CcSEcCtD
Apraclonidine—Ill-defined disorder—Prednisone—atopic dermatitis	0.000651	0.000663	CcSEcCtD
Apraclonidine—Paraesthesia—Triamcinolone—atopic dermatitis	0.00065	0.000662	CcSEcCtD
Apraclonidine—Feeling abnormal—Prednisolone—atopic dermatitis	0.000649	0.000661	CcSEcCtD
Apraclonidine—Paraesthesia—Methylprednisolone—atopic dermatitis	0.000649	0.000661	CcSEcCtD
Apraclonidine—Dyspnoea—Triamcinolone—atopic dermatitis	0.000646	0.000658	CcSEcCtD
Apraclonidine—Nervous system disorder—Betamethasone—atopic dermatitis	0.000644	0.000656	CcSEcCtD
Apraclonidine—Nervous system disorder—Dexamethasone—atopic dermatitis	0.000644	0.000656	CcSEcCtD
Apraclonidine—Feeling abnormal—Hydrocortisone—atopic dermatitis	0.000634	0.000646	CcSEcCtD
Apraclonidine—Malaise—Prednisone—atopic dermatitis	0.000632	0.000644	CcSEcCtD
Apraclonidine—Gastrointestinal pain—Hydrocortisone—atopic dermatitis	0.000629	0.000641	CcSEcCtD
Apraclonidine—Syncope—Prednisone—atopic dermatitis	0.000629	0.00064	CcSEcCtD
Apraclonidine—Fatigue—Triamcinolone—atopic dermatitis	0.000624	0.000636	CcSEcCtD
Apraclonidine—Fatigue—Methylprednisolone—atopic dermatitis	0.000623	0.000635	CcSEcCtD
Apraclonidine—Pain—Triamcinolone—atopic dermatitis	0.000619	0.000631	CcSEcCtD
Apraclonidine—Abdominal pain—Hydrocortisone—atopic dermatitis	0.000608	0.000619	CcSEcCtD
Apraclonidine—Musculoskeletal discomfort—Dexamethasone—atopic dermatitis	0.000599	0.00061	CcSEcCtD
Apraclonidine—Musculoskeletal discomfort—Betamethasone—atopic dermatitis	0.000599	0.00061	CcSEcCtD
Apraclonidine—Myalgia—Prednisone—atopic dermatitis	0.000597	0.000608	CcSEcCtD
Apraclonidine—Feeling abnormal—Triamcinolone—atopic dermatitis	0.000597	0.000608	CcSEcCtD
Apraclonidine—Feeling abnormal—Methylprednisolone—atopic dermatitis	0.000596	0.000607	CcSEcCtD
Apraclonidine—Insomnia—Dexamethasone—atopic dermatitis	0.000594	0.000605	CcSEcCtD
Apraclonidine—Insomnia—Betamethasone—atopic dermatitis	0.000594	0.000605	CcSEcCtD
Apraclonidine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—atopic dermatitis	0.000593	0.000604	CcSEcCtD
Apraclonidine—Gastrointestinal pain—Methylprednisolone—atopic dermatitis	0.000591	0.000602	CcSEcCtD
Apraclonidine—Paraesthesia—Betamethasone—atopic dermatitis	0.00059	0.000601	CcSEcCtD
Apraclonidine—Paraesthesia—Dexamethasone—atopic dermatitis	0.00059	0.000601	CcSEcCtD
Apraclonidine—Discomfort—Prednisone—atopic dermatitis	0.00059	0.000601	CcSEcCtD
Apraclonidine—Hypersensitivity—Prednisolone—atopic dermatitis	0.00058	0.000591	CcSEcCtD
Apraclonidine—Oedema—Prednisone—atopic dermatitis	0.000572	0.000583	CcSEcCtD
Apraclonidine—Abdominal pain—Methylprednisolone—atopic dermatitis	0.000571	0.000582	CcSEcCtD
Apraclonidine—Infection—Prednisone—atopic dermatitis	0.000569	0.000579	CcSEcCtD
Apraclonidine—Gastrointestinal disorder—Dexamethasone—atopic dermatitis	0.000567	0.000578	CcSEcCtD
Apraclonidine—Gastrointestinal disorder—Betamethasone—atopic dermatitis	0.000567	0.000578	CcSEcCtD
Apraclonidine—Hypersensitivity—Hydrocortisone—atopic dermatitis	0.000567	0.000577	CcSEcCtD
Apraclonidine—Fatigue—Dexamethasone—atopic dermatitis	0.000567	0.000577	CcSEcCtD
Apraclonidine—Fatigue—Betamethasone—atopic dermatitis	0.000567	0.000577	CcSEcCtD
Apraclonidine—Pain—Dexamethasone—atopic dermatitis	0.000562	0.000572	CcSEcCtD
Apraclonidine—Pain—Betamethasone—atopic dermatitis	0.000562	0.000572	CcSEcCtD
Apraclonidine—Nervous system disorder—Prednisone—atopic dermatitis	0.000561	0.000572	CcSEcCtD
Apraclonidine—Skin disorder—Prednisone—atopic dermatitis	0.000556	0.000566	CcSEcCtD
Apraclonidine—Asthenia—Hydrocortisone—atopic dermatitis	0.000552	0.000562	CcSEcCtD
Apraclonidine—Pruritus—Hydrocortisone—atopic dermatitis	0.000544	0.000554	CcSEcCtD
Apraclonidine—Feeling abnormal—Dexamethasone—atopic dermatitis	0.000542	0.000552	CcSEcCtD
Apraclonidine—Feeling abnormal—Betamethasone—atopic dermatitis	0.000542	0.000552	CcSEcCtD
Apraclonidine—Gastrointestinal pain—Dexamethasone—atopic dermatitis	0.000537	0.000547	CcSEcCtD
Apraclonidine—Gastrointestinal pain—Betamethasone—atopic dermatitis	0.000537	0.000547	CcSEcCtD
Apraclonidine—Hypersensitivity—Triamcinolone—atopic dermatitis	0.000534	0.000543	CcSEcCtD
Apraclonidine—Hypersensitivity—Methylprednisolone—atopic dermatitis	0.000532	0.000542	CcSEcCtD
Apraclonidine—Diarrhoea—Hydrocortisone—atopic dermatitis	0.000526	0.000536	CcSEcCtD
Apraclonidine—Musculoskeletal discomfort—Prednisone—atopic dermatitis	0.000521	0.000531	CcSEcCtD
Apraclonidine—Dizziness—Prednisolone—atopic dermatitis	0.000521	0.00053	CcSEcCtD
Apraclonidine—Asthenia—Triamcinolone—atopic dermatitis	0.00052	0.000529	CcSEcCtD
Apraclonidine—Abdominal pain—Betamethasone—atopic dermatitis	0.00052	0.000529	CcSEcCtD
Apraclonidine—Abdominal pain—Dexamethasone—atopic dermatitis	0.00052	0.000529	CcSEcCtD
Apraclonidine—Asthenia—Methylprednisolone—atopic dermatitis	0.000518	0.000528	CcSEcCtD
Apraclonidine—Insomnia—Prednisone—atopic dermatitis	0.000518	0.000527	CcSEcCtD
Apraclonidine—Paraesthesia—Prednisone—atopic dermatitis	0.000514	0.000523	CcSEcCtD
Apraclonidine—Pruritus—Triamcinolone—atopic dermatitis	0.000512	0.000522	CcSEcCtD
Apraclonidine—Pruritus—Methylprednisolone—atopic dermatitis	0.000511	0.000521	CcSEcCtD
Apraclonidine—Dizziness—Hydrocortisone—atopic dermatitis	0.000509	0.000518	CcSEcCtD
Apraclonidine—Dermatitis—Prednisolone—atopic dermatitis	0.000496	0.000505	CcSEcCtD
Apraclonidine—Diarrhoea—Methylprednisolone—atopic dermatitis	0.000494	0.000504	CcSEcCtD
Apraclonidine—Fatigue—Prednisone—atopic dermatitis	0.000493	0.000503	CcSEcCtD
Apraclonidine—Headache—Prednisolone—atopic dermatitis	0.000493	0.000503	CcSEcCtD
Apraclonidine—Constipation—Prednisone—atopic dermatitis	0.000489	0.000498	CcSEcCtD
Apraclonidine—Vomiting—Hydrocortisone—atopic dermatitis	0.000489	0.000498	CcSEcCtD
Apraclonidine—Dermatitis—Hydrocortisone—atopic dermatitis	0.000485	0.000493	CcSEcCtD
Apraclonidine—Headache—Hydrocortisone—atopic dermatitis	0.000482	0.000491	CcSEcCtD
Apraclonidine—Dizziness—Triamcinolone—atopic dermatitis	0.000479	0.000488	CcSEcCtD
Apraclonidine—Dizziness—Methylprednisolone—atopic dermatitis	0.000478	0.000487	CcSEcCtD
Apraclonidine—Feeling abnormal—Prednisone—atopic dermatitis	0.000472	0.00048	CcSEcCtD
Apraclonidine—Asthenia—Betamethasone—atopic dermatitis	0.000472	0.00048	CcSEcCtD
Apraclonidine—Asthenia—Dexamethasone—atopic dermatitis	0.000472	0.00048	CcSEcCtD
Apraclonidine—Gastrointestinal pain—Prednisone—atopic dermatitis	0.000468	0.000477	CcSEcCtD
Apraclonidine—Nausea—Prednisolone—atopic dermatitis	0.000468	0.000476	CcSEcCtD
Apraclonidine—Pruritus—Betamethasone—atopic dermatitis	0.000465	0.000474	CcSEcCtD
Apraclonidine—Pruritus—Dexamethasone—atopic dermatitis	0.000465	0.000474	CcSEcCtD
Apraclonidine—Vomiting—Triamcinolone—atopic dermatitis	0.000461	0.000469	CcSEcCtD
Apraclonidine—Vomiting—Methylprednisolone—atopic dermatitis	0.000459	0.000468	CcSEcCtD
Apraclonidine—Nausea—Hydrocortisone—atopic dermatitis	0.000457	0.000465	CcSEcCtD
Apraclonidine—Dermatitis—Triamcinolone—atopic dermatitis	0.000456	0.000465	CcSEcCtD
Apraclonidine—Dermatitis—Methylprednisolone—atopic dermatitis	0.000455	0.000464	CcSEcCtD
Apraclonidine—Headache—Triamcinolone—atopic dermatitis	0.000454	0.000462	CcSEcCtD
Apraclonidine—Headache—Methylprednisolone—atopic dermatitis	0.000453	0.000461	CcSEcCtD
Apraclonidine—Abdominal pain—Prednisone—atopic dermatitis	0.000452	0.000461	CcSEcCtD
Apraclonidine—Diarrhoea—Betamethasone—atopic dermatitis	0.00045	0.000458	CcSEcCtD
Apraclonidine—Diarrhoea—Dexamethasone—atopic dermatitis	0.00045	0.000458	CcSEcCtD
Apraclonidine—Dizziness—Betamethasone—atopic dermatitis	0.000435	0.000443	CcSEcCtD
Apraclonidine—Dizziness—Dexamethasone—atopic dermatitis	0.000435	0.000443	CcSEcCtD
Apraclonidine—Nausea—Triamcinolone—atopic dermatitis	0.00043	0.000438	CcSEcCtD
Apraclonidine—Nausea—Methylprednisolone—atopic dermatitis	0.000429	0.000437	CcSEcCtD
Apraclonidine—Hypersensitivity—Prednisone—atopic dermatitis	0.000422	0.000429	CcSEcCtD
Apraclonidine—Vomiting—Betamethasone—atopic dermatitis	0.000418	0.000426	CcSEcCtD
Apraclonidine—Vomiting—Dexamethasone—atopic dermatitis	0.000418	0.000426	CcSEcCtD
Apraclonidine—Dermatitis—Dexamethasone—atopic dermatitis	0.000414	0.000422	CcSEcCtD
Apraclonidine—Dermatitis—Betamethasone—atopic dermatitis	0.000414	0.000422	CcSEcCtD
Apraclonidine—Headache—Betamethasone—atopic dermatitis	0.000412	0.000419	CcSEcCtD
Apraclonidine—Headache—Dexamethasone—atopic dermatitis	0.000412	0.000419	CcSEcCtD
Apraclonidine—Asthenia—Prednisone—atopic dermatitis	0.000411	0.000418	CcSEcCtD
Apraclonidine—Pruritus—Prednisone—atopic dermatitis	0.000405	0.000412	CcSEcCtD
Apraclonidine—Diarrhoea—Prednisone—atopic dermatitis	0.000392	0.000399	CcSEcCtD
Apraclonidine—Nausea—Dexamethasone—atopic dermatitis	0.00039	0.000398	CcSEcCtD
Apraclonidine—Nausea—Betamethasone—atopic dermatitis	0.00039	0.000398	CcSEcCtD
Apraclonidine—Dizziness—Prednisone—atopic dermatitis	0.000378	0.000385	CcSEcCtD
Apraclonidine—Vomiting—Prednisone—atopic dermatitis	0.000364	0.000371	CcSEcCtD
Apraclonidine—Dermatitis—Prednisone—atopic dermatitis	0.000361	0.000367	CcSEcCtD
Apraclonidine—Headache—Prednisone—atopic dermatitis	0.000359	0.000365	CcSEcCtD
Apraclonidine—Nausea—Prednisone—atopic dermatitis	0.00034	0.000346	CcSEcCtD
Apraclonidine—ADRA2C—GPCR ligand binding—CXCR3—atopic dermatitis	6.63e-05	0.00366	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling by GPCR—CCL27—atopic dermatitis	6.61e-05	0.00364	CbGpPWpGaD
Apraclonidine—ADRA2B—Class A/1 (Rhodopsin-like receptors)—CCL5—atopic dermatitis	6.49e-05	0.00358	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling by GPCR—CCL22—atopic dermatitis	6.48e-05	0.00357	CbGpPWpGaD
Apraclonidine—ADRA2C—GPCRs, Class A Rhodopsin-like—CCR5—atopic dermatitis	6.37e-05	0.00351	CbGpPWpGaD
Apraclonidine—ADRA1A—GPCR downstream signaling—CCL27—atopic dermatitis	6.36e-05	0.00351	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling by GPCR—CCL17—atopic dermatitis	6.34e-05	0.0035	CbGpPWpGaD
Apraclonidine—ADRA2A—G alpha (i) signalling events—CCL5—atopic dermatitis	6.19e-05	0.00341	CbGpPWpGaD
Apraclonidine—ADRA2A—GPCR ligand binding—CCR3—atopic dermatitis	6.16e-05	0.0034	CbGpPWpGaD
Apraclonidine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CXCL10—atopic dermatitis	6.15e-05	0.00339	CbGpPWpGaD
Apraclonidine—ADRA2C—Class A/1 (Rhodopsin-like receptors)—CCL5—atopic dermatitis	6.06e-05	0.00334	CbGpPWpGaD
Apraclonidine—ADRA2A—Hemostasis—SELE—atopic dermatitis	6.03e-05	0.00332	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling by GPCR—CCL22—atopic dermatitis	6.02e-05	0.00332	CbGpPWpGaD
Apraclonidine—ADRA2B—Hemostasis—IL5—atopic dermatitis	6.02e-05	0.00332	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling by GPCR—CCL17—atopic dermatitis	5.93e-05	0.00327	CbGpPWpGaD
Apraclonidine—ADRA1A—GPCR ligand binding—NPS—atopic dermatitis	5.91e-05	0.00326	CbGpPWpGaD
Apraclonidine—ADRA1A—GPCR ligand binding—TAC1—atopic dermatitis	5.91e-05	0.00326	CbGpPWpGaD
Apraclonidine—ADRA2A—GPCR downstream signaling—CCL27—atopic dermatitis	5.91e-05	0.00326	CbGpPWpGaD
Apraclonidine—ADRA2B—Class A/1 (Rhodopsin-like receptors)—CCR5—atopic dermatitis	5.84e-05	0.00322	CbGpPWpGaD
Apraclonidine—ADRA1A—GPCR ligand binding—CXCR3—atopic dermatitis	5.8e-05	0.0032	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling by GPCR—CCL27—atopic dermatitis	5.78e-05	0.00318	CbGpPWpGaD
Apraclonidine—ADRA2B—GPCR ligand binding—CXCL10—atopic dermatitis	5.74e-05	0.00316	CbGpPWpGaD
Apraclonidine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CXCL10—atopic dermatitis	5.72e-05	0.00315	CbGpPWpGaD
Apraclonidine—ADRA2C—Hemostasis—IL5—atopic dermatitis	5.62e-05	0.0031	CbGpPWpGaD
Apraclonidine—ADRA2A—G alpha (i) signalling events—CCR5—atopic dermatitis	5.58e-05	0.00308	CbGpPWpGaD
Apraclonidine—ADRA1A—GPCRs, Class A Rhodopsin-like—CCR5—atopic dermatitis	5.57e-05	0.00307	CbGpPWpGaD
Apraclonidine—ADRA2A—GPCR ligand binding—NPS—atopic dermatitis	5.49e-05	0.00303	CbGpPWpGaD
Apraclonidine—ADRA2A—GPCR ligand binding—TAC1—atopic dermatitis	5.49e-05	0.00303	CbGpPWpGaD
Apraclonidine—ADRA2C—Class A/1 (Rhodopsin-like receptors)—CCR5—atopic dermatitis	5.46e-05	0.00301	CbGpPWpGaD
Apraclonidine—ADRA2A—GPCR ligand binding—CXCR3—atopic dermatitis	5.39e-05	0.00297	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling by GPCR—CCL27—atopic dermatitis	5.37e-05	0.00296	CbGpPWpGaD
Apraclonidine—ADRA2C—GPCR ligand binding—CXCL10—atopic dermatitis	5.36e-05	0.00296	CbGpPWpGaD
Apraclonidine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CCL5—atopic dermatitis	5.3e-05	0.00292	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling by GPCR—CCL17—atopic dermatitis	5.18e-05	0.00286	CbGpPWpGaD
Apraclonidine—ADRA2A—GPCRs, Class A Rhodopsin-like—CCR5—atopic dermatitis	5.18e-05	0.00285	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling by GPCR—CCL11—atopic dermatitis	5.11e-05	0.00282	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—FCER2—atopic dermatitis	5.04e-05	0.00278	CbGpPWpGaD
Apraclonidine—ADRA2B—GPCR ligand binding—CCL5—atopic dermatitis	4.94e-05	0.00272	CbGpPWpGaD
Apraclonidine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CCL5—atopic dermatitis	4.92e-05	0.00271	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling by GPCR—CCL17—atopic dermatitis	4.81e-05	0.00265	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling by GPCR—CCL11—atopic dermatitis	4.78e-05	0.00263	CbGpPWpGaD
Apraclonidine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CCR5—atopic dermatitis	4.77e-05	0.00263	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—FCER2—atopic dermatitis	4.71e-05	0.0026	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—CCL22—atopic dermatitis	4.69e-05	0.00258	CbGpPWpGaD
Apraclonidine—ADRA1A—GPCR ligand binding—CXCL10—atopic dermatitis	4.69e-05	0.00258	CbGpPWpGaD
Apraclonidine—ADRA2C—GPCR ligand binding—CCL5—atopic dermatitis	4.61e-05	0.00254	CbGpPWpGaD
Apraclonidine—ADRA2B—GPCR downstream signaling—CCR3—atopic dermatitis	4.59e-05	0.00253	CbGpPWpGaD
Apraclonidine—ADRA2A—Hemostasis—IL5—atopic dermatitis	4.57e-05	0.00252	CbGpPWpGaD
Apraclonidine—ADRA2B—Platelet activation, signaling and aggregation—IL2—atopic dermatitis	4.46e-05	0.00246	CbGpPWpGaD
Apraclonidine—ADRA2C—Metabolism—GLB1—atopic dermatitis	4.45e-05	0.00246	CbGpPWpGaD
Apraclonidine—ADRA2B—GPCR ligand binding—CCR5—atopic dermatitis	4.45e-05	0.00245	CbGpPWpGaD
Apraclonidine—ADRA2B—G alpha (i) signalling events—CXCL8—atopic dermatitis	4.44e-05	0.00245	CbGpPWpGaD
Apraclonidine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CCR5—atopic dermatitis	4.43e-05	0.00245	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—CCL22—atopic dermatitis	4.38e-05	0.00241	CbGpPWpGaD
Apraclonidine—ADRA2A—GPCR ligand binding—CXCL10—atopic dermatitis	4.35e-05	0.0024	CbGpPWpGaD
Apraclonidine—ADRA2C—GPCR downstream signaling—CCR3—atopic dermatitis	4.29e-05	0.00236	CbGpPWpGaD
Apraclonidine—ADRA2C—Metabolism—ADSL—atopic dermatitis	4.27e-05	0.00235	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—CCL27—atopic dermatitis	4.18e-05	0.0023	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling by GPCR—CCL11—atopic dermatitis	4.18e-05	0.0023	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling by GPCR—CCR3—atopic dermatitis	4.17e-05	0.0023	CbGpPWpGaD
Apraclonidine—ADRA2C—Platelet activation, signaling and aggregation—IL2—atopic dermatitis	4.17e-05	0.0023	CbGpPWpGaD
Apraclonidine—ADRA2C—GPCR ligand binding—CCR5—atopic dermatitis	4.16e-05	0.00229	CbGpPWpGaD
Apraclonidine—ADRA2C—G alpha (i) signalling events—CXCL8—atopic dermatitis	4.15e-05	0.00229	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—FCER2—atopic dermatitis	4.12e-05	0.00227	CbGpPWpGaD
Apraclonidine—ADRA2B—GPCR downstream signaling—TAC1—atopic dermatitis	4.09e-05	0.00226	CbGpPWpGaD
Apraclonidine—ADRA2B—GPCR downstream signaling—NPS—atopic dermatitis	4.09e-05	0.00226	CbGpPWpGaD
Apraclonidine—ADRA1A—GPCR ligand binding—CCL5—atopic dermatitis	4.03e-05	0.00222	CbGpPWpGaD
Apraclonidine—ADRA2B—GPCR downstream signaling—CXCR3—atopic dermatitis	4.01e-05	0.00221	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—CCL27—atopic dermatitis	3.9e-05	0.00215	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling by GPCR—CCR3—atopic dermatitis	3.89e-05	0.00215	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling by GPCR—CCL11—atopic dermatitis	3.88e-05	0.00214	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—CCL22—atopic dermatitis	3.83e-05	0.00211	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—FCER2—atopic dermatitis	3.83e-05	0.00211	CbGpPWpGaD
Apraclonidine—ADRA2C—GPCR downstream signaling—NPS—atopic dermatitis	3.82e-05	0.00211	CbGpPWpGaD
Apraclonidine—ADRA2C—GPCR downstream signaling—TAC1—atopic dermatitis	3.82e-05	0.00211	CbGpPWpGaD
Apraclonidine—ADRA2B—GPCR downstream signaling—IL5—atopic dermatitis	3.8e-05	0.0021	CbGpPWpGaD
Apraclonidine—ADRA1A—GPCR downstream signaling—CCR3—atopic dermatitis	3.75e-05	0.00207	CbGpPWpGaD
Apraclonidine—ADRA2A—GPCR ligand binding—CCL5—atopic dermatitis	3.75e-05	0.00207	CbGpPWpGaD
Apraclonidine—ADRA2C—GPCR downstream signaling—CXCR3—atopic dermatitis	3.75e-05	0.00207	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—CCL17—atopic dermatitis	3.75e-05	0.00207	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling by GPCR—TAC1—atopic dermatitis	3.72e-05	0.00205	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling by GPCR—NPS—atopic dermatitis	3.72e-05	0.00205	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling by GPCR—CXCR3—atopic dermatitis	3.64e-05	0.00201	CbGpPWpGaD
Apraclonidine—ADRA1A—GPCR ligand binding—CCR5—atopic dermatitis	3.63e-05	0.002	CbGpPWpGaD
Apraclonidine—ADRA2A—Metabolism—GLB1—atopic dermatitis	3.62e-05	0.00199	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—CCL22—atopic dermatitis	3.56e-05	0.00196	CbGpPWpGaD
Apraclonidine—ADRA2C—GPCR downstream signaling—IL5—atopic dermatitis	3.55e-05	0.00196	CbGpPWpGaD
Apraclonidine—ADRA2B—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	3.53e-05	0.00195	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—CCL17—atopic dermatitis	3.5e-05	0.00193	CbGpPWpGaD
Apraclonidine—ADRA2A—GPCR downstream signaling—CCR3—atopic dermatitis	3.48e-05	0.00192	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling by GPCR—NPS—atopic dermatitis	3.47e-05	0.00191	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling by GPCR—TAC1—atopic dermatitis	3.47e-05	0.00191	CbGpPWpGaD
Apraclonidine—ADRA2A—Metabolism—ADSL—atopic dermatitis	3.47e-05	0.00191	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling by GPCR—IL5—atopic dermatitis	3.45e-05	0.0019	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—CCL27—atopic dermatitis	3.41e-05	0.00188	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling by GPCR—CCR3—atopic dermatitis	3.4e-05	0.00188	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling by GPCR—CXCR3—atopic dermatitis	3.4e-05	0.00188	CbGpPWpGaD
Apraclonidine—ADRA2A—Platelet activation, signaling and aggregation—IL2—atopic dermatitis	3.38e-05	0.00187	CbGpPWpGaD
Apraclonidine—ADRA2A—GPCR ligand binding—CCR5—atopic dermatitis	3.38e-05	0.00186	CbGpPWpGaD
Apraclonidine—ADRA2A—G alpha (i) signalling events—CXCL8—atopic dermatitis	3.37e-05	0.00186	CbGpPWpGaD
Apraclonidine—ADRA1A—GPCR downstream signaling—TAC1—atopic dermatitis	3.34e-05	0.00184	CbGpPWpGaD
Apraclonidine—ADRA1A—GPCR downstream signaling—NPS—atopic dermatitis	3.34e-05	0.00184	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—KIF3A—atopic dermatitis	3.34e-05	0.00184	CbGpPWpGaD
Apraclonidine—ADRA2C—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	3.3e-05	0.00182	CbGpPWpGaD
Apraclonidine—ADRA1A—GPCR downstream signaling—CXCR3—atopic dermatitis	3.28e-05	0.00181	CbGpPWpGaD
Apraclonidine—ADRA2B—GPCR downstream signaling—CXCL10—atopic dermatitis	3.24e-05	0.00179	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling by GPCR—IL5—atopic dermatitis	3.23e-05	0.00178	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—CCL27—atopic dermatitis	3.17e-05	0.00175	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling by GPCR—CCR3—atopic dermatitis	3.16e-05	0.00174	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—KIF3A—atopic dermatitis	3.12e-05	0.00172	CbGpPWpGaD
Apraclonidine—ADRA1A—GPCR downstream signaling—IL5—atopic dermatitis	3.11e-05	0.00171	CbGpPWpGaD
Apraclonidine—ADRA2A—GPCR downstream signaling—TAC1—atopic dermatitis	3.1e-05	0.00171	CbGpPWpGaD
Apraclonidine—ADRA2A—GPCR downstream signaling—NPS—atopic dermatitis	3.1e-05	0.00171	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—CCL17—atopic dermatitis	3.06e-05	0.00169	CbGpPWpGaD
Apraclonidine—ADRA2A—GPCR downstream signaling—CXCR3—atopic dermatitis	3.04e-05	0.00168	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling by GPCR—TAC1—atopic dermatitis	3.03e-05	0.00167	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling by GPCR—NPS—atopic dermatitis	3.03e-05	0.00167	CbGpPWpGaD
Apraclonidine—ADRA2C—GPCR downstream signaling—CXCL10—atopic dermatitis	3.03e-05	0.00167	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—CMA1—atopic dermatitis	3.02e-05	0.00167	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—CCL11—atopic dermatitis	3.02e-05	0.00167	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling by GPCR—CXCR3—atopic dermatitis	2.98e-05	0.00164	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling by GPCR—CXCL10—atopic dermatitis	2.94e-05	0.00162	CbGpPWpGaD
Apraclonidine—ADRA2A—GPCR downstream signaling—IL5—atopic dermatitis	2.89e-05	0.00159	CbGpPWpGaD
Apraclonidine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	2.89e-05	0.00159	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—CCL17—atopic dermatitis	2.84e-05	0.00157	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—STAT6—atopic dermatitis	2.84e-05	0.00157	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—CMA1—atopic dermatitis	2.82e-05	0.00156	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—CCL11—atopic dermatitis	2.82e-05	0.00156	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling by GPCR—IL5—atopic dermatitis	2.82e-05	0.00156	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling by GPCR—TAC1—atopic dermatitis	2.82e-05	0.00155	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling by GPCR—NPS—atopic dermatitis	2.82e-05	0.00155	CbGpPWpGaD
Apraclonidine—ADRA2B—GPCR downstream signaling—CCL5—atopic dermatitis	2.79e-05	0.00154	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling by GPCR—CXCR3—atopic dermatitis	2.76e-05	0.00152	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling by GPCR—CXCL10—atopic dermatitis	2.75e-05	0.00152	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—KIF3A—atopic dermatitis	2.73e-05	0.0015	CbGpPWpGaD
Apraclonidine—ADRA2B—GPCR ligand binding—CXCL8—atopic dermatitis	2.69e-05	0.00148	CbGpPWpGaD
Apraclonidine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	2.68e-05	0.00148	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—STAT6—atopic dermatitis	2.65e-05	0.00146	CbGpPWpGaD
Apraclonidine—ADRA1A—GPCR downstream signaling—CXCL10—atopic dermatitis	2.65e-05	0.00146	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling by GPCR—IL5—atopic dermatitis	2.62e-05	0.00145	CbGpPWpGaD
Apraclonidine—ADRA2C—GPCR downstream signaling—CCL5—atopic dermatitis	2.61e-05	0.00144	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling by GPCR—CCL5—atopic dermatitis	2.54e-05	0.0014	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—KIF3A—atopic dermatitis	2.53e-05	0.0014	CbGpPWpGaD
Apraclonidine—ADRA2B—GPCR downstream signaling—CCR5—atopic dermatitis	2.51e-05	0.00139	CbGpPWpGaD
Apraclonidine—ADRA2C—GPCR ligand binding—CXCL8—atopic dermatitis	2.51e-05	0.00139	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—CCL11—atopic dermatitis	2.47e-05	0.00136	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—CMA1—atopic dermatitis	2.47e-05	0.00136	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—CCR3—atopic dermatitis	2.46e-05	0.00136	CbGpPWpGaD
Apraclonidine—ADRA2A—GPCR downstream signaling—CXCL10—atopic dermatitis	2.46e-05	0.00136	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling by GPCR—CXCL10—atopic dermatitis	2.4e-05	0.00133	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling by GPCR—CCL5—atopic dermatitis	2.37e-05	0.00131	CbGpPWpGaD
Apraclonidine—ADRA2C—GPCR downstream signaling—CCR5—atopic dermatitis	2.35e-05	0.0013	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—STAT6—atopic dermatitis	2.32e-05	0.00128	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—CCR3—atopic dermatitis	2.3e-05	0.00127	CbGpPWpGaD
Apraclonidine—ADRA2B—Hemostasis—IL2—atopic dermatitis	2.3e-05	0.00127	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—CMA1—atopic dermatitis	2.29e-05	0.00126	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—CCL11—atopic dermatitis	2.29e-05	0.00126	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling by GPCR—CCR5—atopic dermatitis	2.28e-05	0.00126	CbGpPWpGaD
Apraclonidine—ADRA1A—GPCR downstream signaling—CCL5—atopic dermatitis	2.28e-05	0.00126	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling by GPCR—CXCL10—atopic dermatitis	2.23e-05	0.00123	CbGpPWpGaD
Apraclonidine—ADRA1A—GPCR ligand binding—CXCL8—atopic dermatitis	2.2e-05	0.00121	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—NPS—atopic dermatitis	2.19e-05	0.00121	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—TAC1—atopic dermatitis	2.19e-05	0.00121	CbGpPWpGaD
Apraclonidine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—atopic dermatitis	2.19e-05	0.00121	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—STAT6—atopic dermatitis	2.15e-05	0.00119	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—CXCR3—atopic dermatitis	2.15e-05	0.00119	CbGpPWpGaD
Apraclonidine—ADRA2C—Hemostasis—IL2—atopic dermatitis	2.15e-05	0.00118	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling by GPCR—CCR5—atopic dermatitis	2.13e-05	0.00118	CbGpPWpGaD
Apraclonidine—ADRA2A—GPCR downstream signaling—CCL5—atopic dermatitis	2.12e-05	0.00117	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling by GPCR—CCL5—atopic dermatitis	2.07e-05	0.00114	CbGpPWpGaD
Apraclonidine—ADRA1A—GPCR downstream signaling—CCR5—atopic dermatitis	2.05e-05	0.00113	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—NPS—atopic dermatitis	2.05e-05	0.00113	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—TAC1—atopic dermatitis	2.05e-05	0.00113	CbGpPWpGaD
Apraclonidine—ADRA2A—GPCR ligand binding—CXCL8—atopic dermatitis	2.04e-05	0.00113	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—IL5—atopic dermatitis	2.04e-05	0.00113	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—CCR3—atopic dermatitis	2.01e-05	0.00111	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—CXCR3—atopic dermatitis	2.01e-05	0.00111	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling by GPCR—CCL5—atopic dermatitis	1.92e-05	0.00106	CbGpPWpGaD
Apraclonidine—ADRA2A—GPCR downstream signaling—CCR5—atopic dermatitis	1.91e-05	0.00105	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—IL5—atopic dermatitis	1.91e-05	0.00105	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—CCR3—atopic dermatitis	1.87e-05	0.00103	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling by GPCR—CCR5—atopic dermatitis	1.86e-05	0.00103	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—TAC1—atopic dermatitis	1.79e-05	0.000988	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—NPS—atopic dermatitis	1.79e-05	0.000988	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—CXCR3—atopic dermatitis	1.76e-05	0.000969	CbGpPWpGaD
Apraclonidine—ADRA2A—Hemostasis—IL2—atopic dermatitis	1.74e-05	0.000962	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—CXCL10—atopic dermatitis	1.74e-05	0.000959	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling by GPCR—CCR5—atopic dermatitis	1.73e-05	0.000956	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—IL5—atopic dermatitis	1.67e-05	0.000919	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—TAC1—atopic dermatitis	1.67e-05	0.000918	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—NPS—atopic dermatitis	1.67e-05	0.000918	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—CXCR3—atopic dermatitis	1.63e-05	0.0009	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—CXCL10—atopic dermatitis	1.63e-05	0.000896	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—IL5—atopic dermatitis	1.55e-05	0.000854	CbGpPWpGaD
Apraclonidine—ADRA2B—GPCR downstream signaling—CXCL8—atopic dermatitis	1.52e-05	0.000838	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—CCL5—atopic dermatitis	1.5e-05	0.000826	CbGpPWpGaD
Apraclonidine—ADRA2B—GPCR downstream signaling—IL2—atopic dermatitis	1.45e-05	0.000801	CbGpPWpGaD
Apraclonidine—ADRA2C—Metabolism—PPARA—atopic dermatitis	1.44e-05	0.000797	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—CXCL10—atopic dermatitis	1.42e-05	0.000783	CbGpPWpGaD
Apraclonidine—ADRA2C—GPCR downstream signaling—CXCL8—atopic dermatitis	1.42e-05	0.000783	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—CCL5—atopic dermatitis	1.4e-05	0.000771	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—NGF—atopic dermatitis	1.39e-05	0.000765	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling by GPCR—CXCL8—atopic dermatitis	1.38e-05	0.000761	CbGpPWpGaD
Apraclonidine—ADRA2C—GPCR downstream signaling—IL2—atopic dermatitis	1.36e-05	0.000749	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—CCR5—atopic dermatitis	1.35e-05	0.000744	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—CXCL10—atopic dermatitis	1.32e-05	0.000728	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling by GPCR—IL2—atopic dermatitis	1.32e-05	0.000728	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—NGF—atopic dermatitis	1.3e-05	0.000714	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling by GPCR—CXCL8—atopic dermatitis	1.29e-05	0.000711	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—CCR5—atopic dermatitis	1.26e-05	0.000695	CbGpPWpGaD
Apraclonidine—ADRA1A—GPCR downstream signaling—CXCL8—atopic dermatitis	1.24e-05	0.000685	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling by GPCR—IL2—atopic dermatitis	1.23e-05	0.00068	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—CCL5—atopic dermatitis	1.22e-05	0.000674	CbGpPWpGaD
Apraclonidine—ADRA1A—GPCR downstream signaling—IL2—atopic dermatitis	1.19e-05	0.000654	CbGpPWpGaD
Apraclonidine—ADRA2A—Metabolism—PPARA—atopic dermatitis	1.17e-05	0.000647	CbGpPWpGaD
Apraclonidine—ADRA2A—GPCR downstream signaling—CXCL8—atopic dermatitis	1.15e-05	0.000636	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—NFKBIA—atopic dermatitis	1.14e-05	0.000631	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—CCL5—atopic dermatitis	1.14e-05	0.000627	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—NGF—atopic dermatitis	1.13e-05	0.000625	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling by GPCR—CXCL8—atopic dermatitis	1.13e-05	0.000622	CbGpPWpGaD
Apraclonidine—ADRA2A—GPCR downstream signaling—IL2—atopic dermatitis	1.1e-05	0.000608	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—CCR5—atopic dermatitis	1.1e-05	0.000608	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling by GPCR—IL2—atopic dermatitis	1.08e-05	0.000594	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—NFKBIA—atopic dermatitis	1.07e-05	0.000589	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—NGF—atopic dermatitis	1.05e-05	0.00058	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling by GPCR—CXCL8—atopic dermatitis	1.05e-05	0.000578	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—CCR5—atopic dermatitis	1.02e-05	0.000564	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling by GPCR—IL2—atopic dermatitis	1e-05	0.000552	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—NFKBIA—atopic dermatitis	9.34e-06	0.000515	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—NFKBIA—atopic dermatitis	8.68e-06	0.000479	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—CXCL8—atopic dermatitis	8.16e-06	0.00045	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—IL2—atopic dermatitis	7.8e-06	0.00043	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling by GPCR—IL6—atopic dermatitis	7.76e-06	0.000428	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—CXCL8—atopic dermatitis	7.62e-06	0.00042	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—IL2—atopic dermatitis	7.28e-06	0.000402	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling by GPCR—IL6—atopic dermatitis	7.24e-06	0.0004	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—MAPK8—atopic dermatitis	7.18e-06	0.000396	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—MAPK8—atopic dermatitis	6.7e-06	0.00037	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—CXCL8—atopic dermatitis	6.66e-06	0.000367	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—IL2—atopic dermatitis	6.37e-06	0.000351	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling by GPCR—IL6—atopic dermatitis	6.33e-06	0.000349	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—CXCL8—atopic dermatitis	6.19e-06	0.000341	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—IL2—atopic dermatitis	5.91e-06	0.000326	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling by GPCR—IL6—atopic dermatitis	5.88e-06	0.000325	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—MAPK8—atopic dermatitis	5.86e-06	0.000323	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—MAPK8—atopic dermatitis	5.44e-06	0.0003	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—IL6—atopic dermatitis	4.58e-06	0.000253	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—IL6—atopic dermatitis	4.28e-06	0.000236	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—IL6—atopic dermatitis	3.74e-06	0.000206	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—IL6—atopic dermatitis	3.48e-06	0.000192	CbGpPWpGaD
